CD4 and cancer: Of note, some cancer types, which had RORs higher than would be predicted by the TMB – CD4+ naive T-cells model, exhibited higher DC abundance (e.g., lung adenocarcinoma), and some with lower-than-predicted RORs showed lower DC abundance (e.g., glioma) (Figure 2B).